What Are the First Signs of Peripheral Neuropathy?

The first signs of peripheral neuropathy are usually sensory: numbness, tingling ("pins and needles"), or burning pain that starts in the toes and feet and slowly moves upward. These symptoms reflect damage to the longest nerve fibers first — a pattern called length-dependent neuropathy. Catching these early signs and identifying the cause is critical, because for the most common cause (diabetes), slowing progression is possible with better glucose control.

This guide draws on peer-reviewed research from three specialists whose work defines how peripheral neuropathy is diagnosed and treated today: Eva Feldman, MD, PhD, whose staging framework for diabetic neuropathy has been cited over 1,200 times [1]; Brian Callaghan, MD, lead author of an authoritative Nature Reviews Disease Primers entry on diabetic neuropathy [4] and a widely read JAMA review of distal symmetric polyneuropathy [5]; and Rodica Busui, MD, PhD, whose research on neuropathy subtypes [6] and the role of glucose control [7] has shaped clinical practice guidelines.

What is peripheral neuropathy?

Peripheral neuropathy is damage to the peripheral nervous system — the nerves that run outside the brain and spinal cord, carrying signals between the central nervous system and the rest of the body. Those signals include sensation (touch, pain, temperature, vibration), motor commands (voluntary movement), and autonomic functions (heart rate, digestion, sweating, bladder control). Neuropathy can affect any or all three of these nerve types.

Approximately 20 million Americans have some form of peripheral neuropathy. Diabetes is by far the most common cause: up to half of all people with diabetes will develop diabetic peripheral neuropathy over the course of their disease [4]. Other important causes include chronic alcohol use, vitamin B12 deficiency, toxic drug exposures (especially certain chemotherapy agents), immune-mediated conditions such as chronic inflammatory demyelinating polyneuropathy (CIDP), and hereditary syndromes. In roughly 20 to 30 percent of cases, no cause is found even after a thorough workup — a category called idiopathic neuropathy.

The first symptoms to notice

The earliest and most consistent symptoms of peripheral neuropathy are sensory, and they almost always begin in the toes and the balls of the feet. Common descriptions include:

• Numbness or reduced sensation — feet feel "asleep" even when you are moving, or you notice you cannot feel temperature changes in bath water
• Tingling or "pins and needles" — an ongoing buzzing or prickling sensation, often described as feeling like you are wearing thin socks you cannot take off
• Burning pain — a deep, persistent burning that is often worst at night, when the warmth of bedclothes and the absence of daytime distraction make it more noticeable
• Loss of vibration sense — you may notice this first on uneven pavement, cobblestones, or walking barefoot on grass, where you cannot feel the ground texture the way you used to

Feldman and colleagues developed a practical two-step clinical and electrophysiological staging system for diabetic neuropathy that maps how these sensory features accumulate as the condition progresses [1]. In its earliest stage, objective nerve conduction changes are present without obvious symptoms. By the time most patients notice anything, some measurable nerve function has already been lost. This is one reason clinicians advocate for regular screening in high-risk patients — waiting for symptoms means the window for the most aggressive risk-factor modification has already narrowed.

Length-dependent pattern: why feet first?

The reason peripheral neuropathy almost always starts in the feet comes down to anatomy. The nerves that serve the toes and the soles of the feet are the longest in the body, running from the lumbar spine all the way down the legs. Long nerve fibers are metabolically demanding and, when damaged by glucose toxicity, nutrient deficiency, or toxic exposures, tend to fail from the distal (far) end first. This produces the characteristic "stocking-and-glove" distribution, where symptoms start at the tips of the toes, gradually ascend toward the ankles and calves, and — in more advanced disease — eventually reach the fingers and hands as well.

This pattern is called distal symmetric polyneuropathy (DSPN), and it accounts for the majority of all peripheral neuropathy cases. A 2015 review in JAMA by Callaghan and colleagues described DSPN as the most common form of neuropathy encountered in clinical practice and outlined both its staged progression and the evidence base for identifying treatable causes [5]. In early disease, symptoms may be confined to the toes. Over months to years, without treatment of the underlying cause, the affected zone marches slowly upward.

Large vs. small fiber neuropathy symptoms

Not all nerve fibers fail at the same rate or produce the same symptoms. Neurologists distinguish between large-fiber and small-fiber involvement, and the distinction matters because the two subtypes show up differently on examination and tests.

Large-fiber neuropathy affects the myelinated fibers that carry vibration sense and proprioception (joint position sense) and that drive tendon reflexes. Early large-fiber signs include a reduced or absent ankle jerk reflex, diminished ability to feel a vibrating tuning fork at the great toe, and a sense of unsteadiness when walking in the dark or on uneven ground. Falls become more common as the condition progresses because proprioception — knowing where your foot is without looking at it — becomes unreliable.

Small-fiber neuropathy affects unmyelinated and thinly myelinated fibers that carry pain and temperature signals and regulate autonomic functions. Burning pain, heat intolerance, and allodynia (pain from a stimulus that should not hurt, like a light bedsheet touching the feet) are hallmarks. Autonomic features can appear at the same time: dry feet due to reduced sweat gland activity, episodic flushing, or early problems with bladder function. Busui and colleagues have characterized the distinct subtypes of diabetic neuropathy and their underlying mechanisms in detail, showing that small-fiber dysfunction often precedes measurable changes on standard nerve conduction testing [6]. A 2017 paper in Neuron from the Feldman group explored the bioenergetic and metabolic mechanisms driving this kind of early small-fiber damage, emphasizing that painful neuropathy and painless neuropathy represent different disease states — not just different points on the same continuum [2].

When symptoms appear in other patterns

Most peripheral neuropathy follows the length-dependent, feet-first pattern described above. When symptoms appear in a different distribution, the cause is usually different as well.

Non-length-dependent patterns — numbness or pain involving the face, the torso, or both sides asymmetrically — suggest an immune-mediated cause, a vasculitic process, or a paraneoplastic syndrome associated with an underlying malignancy. These patterns warrant a more urgent workup.

Mononeuropathy — damage to a single nerve — produces symptoms in the territory of that nerve rather than a diffuse stocking distribution. Carpal tunnel syndrome (median nerve at the wrist), cubital tunnel syndrome (ulnar nerve at the elbow), and peroneal palsy (the nerve that runs around the outer knee, causing foot drop) are common examples. Mononeuropathies often have a mechanical or compressive cause and are frequently treatable.

Autonomic neuropathy can appear alongside somatic neuropathy or, in some patients, as the dominant presentation. Symptoms include lightheadedness on standing (orthostatic hypotension), early satiety and nausea from delayed gastric emptying (gastroparesis), erectile dysfunction in men, and exercise intolerance. In diabetes, autonomic neuropathy is a marker of more advanced nerve injury and carries implications for cardiovascular risk.

Common causes and which ones are reversible

The practical importance of identifying the cause of neuropathy is that reversibility varies dramatically.

• Diabetes: The most common cause. Nerve damage from chronic hyperglycemia is not fully reversible, but clinical trials have shown that tighter glucose control, especially early in the course of disease, can slow progression [7]. In type 1 diabetes the evidence is particularly strong; in type 2 the benefit is more modest but still present.
• Vitamin B12 deficiency: Highly reversible if caught early. B12 deficiency is common in older adults, in long-term users of metformin, and in people following a strict vegan diet without supplementation. Restoring normal B12 levels halts progression and can reverse early symptoms.
• Alcohol: Alcohol-related neuropathy improves substantially with abstinence and nutritional support, particularly thiamine (B1) repletion.
• Medications: Certain chemotherapy agents — cisplatin, taxanes, thalidomide — cause dose-dependent peripheral neuropathy. Symptoms may partially improve after completing treatment, but some residual damage often persists.
• Immune-mediated (CIDP): Treatable with intravenous immunoglobulin, corticosteroids, or plasma exchange. Early treatment substantially improves outcomes.

What a neurologist will do

A neurologist evaluating possible peripheral neuropathy will begin with a structured physical examination. The standard tools are simple but informative: a 10-gram monofilament pressed against the bottom of the foot (tests pressure sensation), a 128-Hz tuning fork applied to the great toe (tests vibration sense), and a reflex hammer at the ankle. Feldman and colleagues validated this kind of two-step examination approach as both practical and sufficiently accurate for staging and tracking neuropathy in clinical settings [1][3].

When the examination suggests neuropathy, the next step is usually nerve conduction studies and electromyography (EMG). These tests measure how fast electrical signals travel along specific nerves and whether the electrical activity in muscles looks normal. They are the gold standard for confirming large-fiber neuropathy and for differentiating polyneuropathy from mononeuropathy.

Blood tests look for the most common treatable causes: fasting glucose and hemoglobin A1c (diabetes), B12 and folate, thyroid function, a complete blood count, and a metabolic panel. If immune-mediated disease is suspected, additional testing for specific antibodies may follow.

For suspected small-fiber neuropathy, where nerve conduction studies may be normal despite significant symptoms, a skin punch biopsy taken from the leg can count the density of intraepidermal nerve fibers under a microscope. Reduced fiber density confirms small-fiber neuropathy and can be followed over time to track progression or response to treatment.

When to seek evaluation

See a neurologist if you notice any of the following:

• Numbness, tingling, or burning in both feet simultaneously — this bilateral, symmetric pattern is the hallmark of polyneuropathy rather than a pinched nerve
• Symptoms that have spread above the ankle level
• Any new weakness in the feet or legs, difficulty lifting the foot (foot drop), or unexplained stumbling
• Autonomic symptoms such as lightheadedness when standing, unexplained changes in sweating on the feet, or sexual dysfunction alongside sensory symptoms
• Symptoms in a person with diabetes or prediabetes, even if mild — early identification changes the management plan

Questions to ask your neurologist

• Based on my exam and nerve conduction studies, do I have large-fiber involvement, small-fiber involvement, or both?
• What is the most likely cause, and are there reversible causes we should test for?
• How quickly is this likely to progress if the underlying cause is not addressed?
• What can I do right now — whether that is glucose management, stopping alcohol, or a medication change — to stop or slow the damage?
• If my symptoms are painful, what treatment options are available, and how do they compare in terms of effectiveness and side effects?

The bottom line

The earliest signs of peripheral neuropathy — numbness and tingling starting in the toes, burning pain at night, a subtle loss of vibration sense — are easy to attribute to tired feet or poor circulation and dismiss. They should not be dismissed. Peripheral neuropathy is common, progressive when untreated, and in many cases linked to a cause that can be modified. The research that defines how the condition is staged, what drives it at the cellular level, and how glucose control affects its trajectory makes one point consistently clear: earlier evaluation means better options. If your feet have been telling you something is different, a neurologist can find out why.